Normal view MARC view ISBD view

Recycling of distillery effluents in alcoholic fermentation: role in inhibition of 10 organic molecules. [electronic resource]

By:

Couallier, E Morin

Contributor(s):

Producer: 20060905Description: 217-38 p. digitalISSN:

0273-2289

Subject(s):

Online resources:

Available from publisher's website

In: Applied biochemistry and biotechnology vol. 133

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

321 [Coagulation and extracorporeal circulation with deep hypothermia].
by SAMAMA, M
322 [Technics and results of systematic peroperative surveillance of coagulation in open-heart surgery].
by MARCHAL, G
323 [FIBRINOLYTIC HYPERACTIVITY DURING CARDIAC SURGERY WITH EXTRACORPOREAL CIRCULATION. STUDY BASED ON 280 OPERATIONS].
by SAMAMA, M
324 Proceedings: Role of trisodium citrate in the unclottability by thrombin of fibrinogen Metz.
by Soria, C
325 Effect of standard heparin and a low molecular weight heparin on thrombolytic and fibrinolytic activity of single-chain urokinase plasminogen activator in vitro.
by Lourenço, D M
326 Clinical studies with low molecular weight heparins in the prevention and treatment of venous thromboembolism.
by Samama, M
327 [Protein C].
by Conard, J
328 [Lipolytic and anticoagulant activities of heparin and one of its low molecular weight derivatives].
by Millot, F
329 Platelet and red-cell fragments in thrombocytopenia.
by Le Tohic, F
330 Severe protein C deficiency in congenital thrombotic disease--description of an immunoenzymological assay for protein C determination.
by Soria, J
331 Red blood cell aggregability in patients with a history of leg vein thrombosis: influence of post-thrombotic treatment.
by Chabanel, A
332 [A new cause of hereditary venous thrombosis: activated protein C resistance].
by Trossaërt, M
333 [Anticardiolipin antibodies and thrombosis].
by Bentolila, S
334 On a case of pure vascular von Willebrand disease.
by MARCHAL, G
335 [Treatment of an acute fibrinolytic complication with a new antiproteolytic agent during a portacaval anastomosis].
by MARCHAL, G
336 [Direct tests of exploration of the thrombodynamic function of the platelets].
by MARCHAL, G
337 [FIBRINOLYTIC HYPERACTIVITY IN 280 OPEN-HEART SURGERY PATIENTS. CLINICAL CORRELATIONS AND THERAPEUTIC RESULTS].
by SAMAMA, M
338 [Cataclysmic fibrinolytic complications observed during open-heart surgery].
by WEISS, M
339 Marked potentiation of the plasminogenolytic activity of pro-urokinase by unfractionated heparin and a low molecular-weight heparin.
by Dosne, A M
340 [Problems posed by the treatment of deep venous thrombosis in patients with a coagulopathy].
by Conard, J